Moving up... and moving on

Promotions across Australian pharma appear to be flavour of the month for June with executives taking an internal path to climbing the ladder - though there have been a couple of high profile departures too.

AstraZeneca's Luke Unicomb has a new and expanded role as the company gets cracking on a "new era of growth" announced last month.

"AstraZeneca has recently unveiled our bold ambition to launch 20 new products by 2030. I'm thrilled to lead our medical team as Associate Medical Director; Respiratory & Immunology, Vaccines & Immune Therapies as we advance and shape the future of medicine," he said on LinkedIn.